HOME >> BIOLOGY >> NEWS
Other highlights in the February 4 issue of JNCI

Questions Linger About Use of Partial Breast Irradiation

The growing interest in partial-breast irradiation (PBI) and accelerated partial-breast irradiation (APBI) for treatment of early-stage breast cancer make clear the need for ongoing dialogue and well-designed clinical studies of the radiation techniques, concludes a commentary in the February 4 issue of the Journal of the National Cancer Institute.

Breast-conserving therapy has been accepted as an alternative to mastectomy in the management of early-stage breast cancer. Because of the increasing interest in PBI--a technique that directs radiation only at the portion of the breast at high risk for recurrence--and in APBI--which has an accelerated schedule of treatment--the National Cancer Institute hosted a workshop in which issues regarding the equivalency of various radiation therapy approaches and the future needs for research were discussed.

In the commentary, Paul E. Wallner, D.O., and C. Norman Coleman, M.D., of the National Cancer Institute, and colleagues present a summary of the workshop. The authors review the current technology and current science relating to PBI and APBI, and they highlight the need for additional research, training, quality assurance, and procedure standardization.

Preoperative Chemoradiation May Benefit Some Patients with Rectal Cancer

Chemotherapy plus radiation therapy is beneficial for some patients with localized rectal cancer who are carefully selected based on the stage of their disease, according to a new study that uses a statistical model.

Although radical resection and chemoradiation (treatment with both chemotherapy and radiation therapy) after surgery have been the standard therapy for patients with rectal cancer, chemoradiation before surgery is widely used when the extent of the disease is determined through clinical staging. However, there is little information available that directly compares these two appro
'"/>

Contact: Katherine Arnold
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
3-Feb-2004


Page: 1 2 3 4

Related biology news :

1. Other highlights in the September 1 JNCI
2. Other highlights in the August 18 JNCI
3. Other highlights in the August 4 JNCI
4. Other highlights in the July 7 JNCI
5. Other highlights in the June 16 JNCI
6. Other Highlights in the June 2 JNCI
7. Other highlights in the May 19 JNCI
8. Other highlights in the May 5 JNCI
9. Other highlights of the March 17 issue of JNCI
10. Other highlights in the March 3 issue of JNCI
11. Other highlights in the February 18 issue of JNCI

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Other highlights the February issue JNCI

(Date:6/13/2013)... Mass. - Qiaobing Xu, assistant professor of biomedical ... named a Pew Scholar in Biomedical Sciences by ... competitive program, whose past winners have included Nobel ... Albert Lasker Basic Medical Research Award, identifies talented ... focuses on nanotechnology for biomedical uses. He will ...
(Date:6/13/2013)... named Pew Latin American Fellows in the Biomedical ... fellowship provides support to advance grantees, research, enables ... invests seed capital to help them establish laboratories ... to postdoctoral researchers investigating some of the world,s ... , "The quest for impactful biomedical discoveries is ...
(Date:6/13/2013)... PHILADELPHIA (June 13, 2013)Twenty-two of the nation,s most ... Biomedical Sciences by The Pew Charitable Trusts today. ... researching the basis of perplexing health problems such ... new scholars join a prestigious community of researchers ... MacArthur fellows, Albert Lasker Basic Medical Research Award ...
Breaking Biology News(10 mins):Tufts Engineer Qiaobing Xu named 2013 Pew Scholar 2On the scientific frontier 2On the scientific frontier 3From autism to diabetes to Parkinson's disease 2From autism to diabetes to Parkinson's disease 3
(Date:6/14/2013)... Ventura, CA (PRWEB) June 14, 2013 ... Twist Lock Couplings come equipped with a new and ... with a non-slip, more secure grip and reliable connection ... particularly well suited for use on medical applications ... range offers blood pressure cuff manufacturers with better, more ...
(Date:6/14/2013)... Rosacea is said to affect 16 million Americans, eczema, another ... seems that most of the population have one or more ... reports, often deciphering the difference between one skin condition and ... similar symptoms. Probiotic Action explains how these skin conditions are ... , Rosacea, Acne and Eczema are conditions that react to ...
(Date:6/14/2013)... Pittsburgh Life Sciences Greenhouse (PLSG) today announced a reduction ... by delays in portfolio company exits caused primarily by ... funding. PLSG President and CEO, John ... life sciences investment firm, the actions taken this week, ... were necessary to protect the future of both our ...
(Date:6/13/2013)... Eagle Biosciences is proud to announce ... Calprotectin ELISA assay kit that offers the ... µg/g stool). The Calprotectin ELISA assay kit is ... Calprotectin (neutrophil cytoplasmic protein s100A8/A9, MRP 8/14) in ... assay line which already includes Alpha 1 Antitrypsin ...
Breaking Biology Technology:LinkTech Inc. Launches Ideal Replacement for a Luer Fitting 2LinkTech Inc. Launches Ideal Replacement for a Luer Fitting 3Rosacea, Acne, or Eczema? Probiotic Action Offers a Topical Probiotic to Treat the Most Common Skin Conditions 2Pittsburgh Life Sciences Greenhouse Makes Significant Reductions Due to Uncertain Funding 2Eagle Biosciences Introduces Highly Sensitive Calprotectin ELISA Assay Kit 2
Cached News: